ID   iPD-T2
AC   CVCL_A4MP
DR   SKIP; SKIP003175
DR   Wikidata; Q105509693
RX   PubMed=29513666;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; chr12:g.40197315A; dbSNP=rs1491923; Zygosity=Unspecified (PubMed=29513666).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
RX   PubMed=29513666; DOI=10.1371/journal.pone.0192497; PMCID=PMC5841660;
RA   Marrone L., Bus C., Schondorf D.C., Fitzgerald J.C., Kubler M.,
RA   Schmid B., Reinhardt P., Reinhardt L., Deleidi M., Levin T.,
RA   Meixner A., Klink B., Glatza M., Gloeckner C.J., Gasser T.,
RA   Sterneckert J.;
RT   "Generation of iPSCs carrying a common LRRK2 risk allele for in vitro
RT   modeling of idiopathic Parkinson's disease.";
RL   PLoS ONE 13:E0192497-E0192497(2018).
//